BOSTON--(BUSINESS WIRE)--PureTech Health plc (“PureTech” or the “Company”, LSE: PRTC), a cross-disciplinary biotech company developing novel medicines at the interface of the gut, brain and immune system, today announced the appointment of Feng Zhang, Ph.D. to its Scientific Advisory Board (SAB). The Company has also appointed Jeff Stevens, as Vice President of Growth Strategy & Operations and has expanded its team of senior advisors to include Meghan Fitzgerald, DrPH, Executive Vice President of Corporate Strategy, M&A and Health Policy at Cardinal Health; Atul Pande, M.D., Former Senior Vice President and Head of Neurosciences at GlaxoSmithKline; and Philip J. Larsen, M.D., Ph.D., Global Head of Diabetes Research & Development at Sanofi.
